- In December 2024, Australia introduced the first combined topical solution of 0.5% 5‑fluorouracil and 10% salicylic acid for actinic keratosis. This innovative formulation offers enhanced efficacy for field treatment of multiple lesions, marking a significant advance in keratolytic combination therapies
- In April 2025, Kingskin voluntarily recalled lots of its 17% salicylic acid topical solution (FDA Class II). The recall serves as a reminder of the importance of rigorous quality control and safety in the rapidly expanding keratolytics field
